Clinical Trial Update: Dose-response Study of Efficacy and Safety of Botulinum Toxin Type A to Treat Spasticity of the Leg(s) in Cerebral Palsy [Phase 3]

View source ↗

Summary

Phase 3 dose-response study evaluating botulinum toxin type A for lower limb spasticity due to cerebral palsy has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Palsy
• Lower Limb Spasticity

Drugs mentioned

• Botulinum toxin type A (botulinum toxin type A)

Snippet

Sponsor: Merz Pharmaceuticals GmbH | Conditions: Lower Limb Spasticity Due to Cerebral Palsy | Phase 3 | Status: COMPLETED | Results posted: 2017-05-12